Skip to main content
. 2023 Dec 1;108(12):3204–3210. doi: 10.3324/haematol.2023.282719

Table 2.

Selected drugs, their targets and disease rationale under study in peripheral T-cell lymphoma/mature NK/T-cell neoplasms.

graphic file with name 1083204.tab2.jpg